S. Jane Darnton

1.6k total citations
41 papers, 1.0k citations indexed

About

S. Jane Darnton is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, S. Jane Darnton has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in S. Jane Darnton's work include Esophageal Cancer Research and Treatment (20 papers), Gastric Cancer Management and Outcomes (10 papers) and Esophageal and GI Pathology (7 papers). S. Jane Darnton is often cited by papers focused on Esophageal Cancer Research and Treatment (20 papers), Gastric Cancer Management and Outcomes (10 papers) and Esophageal and GI Pathology (7 papers). S. Jane Darnton collaborates with scholars based in United Kingdom, United States and Canada. S. Jane Darnton's co-authors include Alan G. Casson, H R Matthews, Janusz Jankowski, Rebecca Harrison, Laura J. Hardie, Christopher P. Wild, Karilyn Larkin, J. A. Barrowman, Louise Hiller and Nicholas A. Wright and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

S. Jane Darnton

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Jane Darnton United Kingdom 17 525 406 338 242 132 41 1.0k
Anya N. Milne Netherlands 18 478 0.9× 365 0.9× 382 1.1× 473 2.0× 161 1.2× 32 1.1k
Yasuji Yoshikawa Japan 17 171 0.3× 522 1.3× 260 0.8× 330 1.4× 125 0.9× 51 1.1k
Masao Tanaka Japan 16 515 1.0× 270 0.7× 230 0.7× 504 2.1× 103 0.8× 30 996
Kazunori Shibao Japan 17 423 0.8× 596 1.5× 225 0.7× 456 1.9× 98 0.7× 81 1.3k
Dirk Uhlmann Germany 19 688 1.3× 320 0.8× 302 0.9× 381 1.6× 100 0.8× 43 1.2k
Annalisa Altimari Italy 20 269 0.5× 380 0.9× 259 0.8× 389 1.6× 255 1.9× 72 1.1k
H Makuuchi Japan 17 408 0.8× 189 0.5× 351 1.0× 358 1.5× 98 0.7× 70 929
Kanenori Endo Japan 17 332 0.6× 369 0.9× 148 0.4× 365 1.5× 170 1.3× 37 890
Yutaka Sanada Japan 21 294 0.6× 669 1.6× 205 0.6× 413 1.7× 231 1.8× 88 1.2k
Isamu Kino Japan 23 391 0.7× 439 1.1× 284 0.8× 430 1.8× 172 1.3× 81 1.3k

Countries citing papers authored by S. Jane Darnton

Since Specialization
Citations

This map shows the geographic impact of S. Jane Darnton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Jane Darnton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Jane Darnton more than expected).

Fields of papers citing papers by S. Jane Darnton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Jane Darnton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Jane Darnton. The network helps show where S. Jane Darnton may publish in the future.

Co-authorship network of co-authors of S. Jane Darnton

This figure shows the co-authorship network connecting the top 25 collaborators of S. Jane Darnton. A scholar is included among the top collaborators of S. Jane Darnton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Jane Darnton. S. Jane Darnton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boonstra, Jurjen J., Ronald van Marion, David G. Beer, et al.. (2010). Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell Lines. JNCI Journal of the National Cancer Institute. 102(4). 271–274. 97 indexed citations
2.
3.
4.
Hardie, Laura J., S. Jane Darnton, Yvonne Wallis, et al.. (2004). p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations. Cancer Letters. 217(2). 221–230. 63 indexed citations
5.
Casson, Alan G., Susan C. Evans, Amy Gillis, et al.. (2003). Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study. Journal of Thoracic and Cardiovascular Surgery. 125(5). 1121–1131. 43 indexed citations
6.
Tselepis, Chris, Ian Perry, Chris Dawson, et al.. (2002). Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action. Oncogene. 21(39). 6071–6081. 141 indexed citations
7.
Brown, Rachel M., et al.. (2002). A primary tumour of the oesophagus with both melanocytic and schwannian differentiation. Melanocytic schwannoma or malignant melanoma?. Journal of Clinical Pathology. 55(4). 318–320. 11 indexed citations
8.
Casson, Alan G., S. Jane Darnton, Sujata Subramanian, & Louise Hiller. (2000). What is the optimal distal resection margin for esophageal carcinoma?. The Annals of Thoracic Surgery. 69(1). 205–209. 52 indexed citations
9.
Dinjens, Winand N.M., et al.. (2000). True. British Journal of Cancer. 82(9). 1510–1512. 5 indexed citations
10.
Sanders, D. S. A., et al.. (1998). Sequential changes in cadherin‐catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. International Journal of Cancer. 79(6). 573–579. 3 indexed citations
11.
Sanders, D. S. A., et al.. (1998). Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. International Journal of Cancer. 79(6). 573–579. 43 indexed citations
12.
Coatesworth, A. P., et al.. (1998). A case of systemic pseudo-pseudoxanthoma elasticum with diverse symptomatology caused by long-term penicillamine use.. Journal of Clinical Pathology. 51(2). 169–171. 14 indexed citations
13.
Darnton, S. Jane. (1998). Demystified ... p53.. Molecular Pathology. 51(5). 248–253. 14 indexed citations
14.
Darnton, S. Jane, D. Ferry, M.H. Cullen, & Alan G. Casson. (1998). A phase II trial of preoperative mitomycin, cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagus. Clinical Oncology. 10(6). 372–376. 2 indexed citations
15.
Steyn, Richard, et al.. (1998). A Phase II trial of four courses of preoperative chemotherapy in squamous or anaplastic carcinoma of the oesophagus. Clinical Oncology. 10(3). 165–169. 2 indexed citations
16.
Larkin, Karilyn, et al.. (1997). Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. British Journal of Cancer. 75(2). 258–263. 102 indexed citations
17.
Allen, Simon, et al.. (1996). Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus. Cancer Chemotherapy and Pharmacology. 37(5). 496–498. 8 indexed citations
18.
Steyn, Richard, et al.. (1995). Weight gain as an indicator of response to chemotherapy for oesophageal carcinoma. Clinical Oncology. 7(6). 382–384. 11 indexed citations
19.
Allen, Simon, John P. Duffy, Steven J. Walker, et al.. (1994). A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus. Clinical Oncology. 6(2). 91–95. 11 indexed citations
20.
Newman, Joseph T., et al.. (1992). The ultrastructure of oesophageal carcinomas: Multidirectional differentiation. A transmission electron microscopic study of 43 cases. The Journal of Pathology. 167(2). 193–198. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anya N. Milne Breakdown of academic impact, for papers by Yasuji Yoshikawa Breakdown of academic impact, for papers by Masao Tanaka Breakdown of academic impact, for papers by Kazunori Shibao Breakdown of academic impact, for papers by Dirk Uhlmann Breakdown of academic impact, for papers by Annalisa Altimari Breakdown of academic impact, for papers by H Makuuchi Breakdown of academic impact, for papers by Kanenori Endo Breakdown of academic impact, for papers by Yutaka Sanada Breakdown of academic impact, for papers by Isamu Kino
Rankless by CCL
2026